Model
Edge
Relmada Therapeutics, Inc.
RLMD
Filing Type
POS AM
Filing Date
10/24/2019
Updated
10/25/19, 10:10 AM
Filing
POS AM
Earnings Release
Exhibits
POS AM
Post-Effective Amendment to Registration Statement
EX-5.1
OPINION OF SICHENZIA ROSS FERENCE LLP.
EX-23.1
CONSENT OF MARCUM LLP
GRAPHIC
Graphic